• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Poisoning - Pipeline Review, H1 2012 Product Image

Poisoning - Pipeline Review, H1 2012

  • ID: 2021902
  • January 2012
  • 54 pages
  • Global Markets Direct

Poisoning – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, 'Poisoning - Pipeline Review, H1 2012', provides an overview of the Poisoning therapeutic pipeline. This report provides information on the therapeutic development for Poisoning, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Poisoning. 'Poisoning - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Poisoning.
- A review of the Poisoning products under development by companies and universities/research institutes based on information derived from company and industry-specific READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Poisoning Overview
Therapeutics Development
An Overview of Pipeline Products for Poisoning
Poisoning Therapeutics under Development by Companies
Poisoning Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Poisoning Therapeutics – Products under Development by Companies
Poisoning Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Poisoning Therapeutics Development
Cangene Corporation
Protalix BioTherapeutics, Inc.
Aton Pharma, Inc.
MicroDose Therapeutx, Inc.
Instituto Bioclon S.A. de C.V.
Poisoning – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
PRX-105 - Drug Profile
Atropine Sulfate - Drug Profile
Ricin Immune Globulin - Drug Profile
Clonidine - Drug Profile
Fructose-1,6-Diphosphate - Drug Profile
Carboplatin + Sodium Thiosulfate - Drug Profile
Buprenorphine + Naloxone - Drug Profile
ATON 004 - Drug Profile
ATON 009 - Drug Profile
Penicillamine - Drug Profile
VINS Polyvalent Antivenom - Drug Profile
Atropine Sulfate - Drug Profile
Equine F(ab')2 Antivenom - Drug Profile
Alpha-Ketoglutarate + Sodium Thiosulphate - Drug Profile
Poisoning Therapeutics – Drug Profile Updates
Poisoning Therapeutics - Dormant Products
Poisoning – Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Poisoning, H1 2012
Products under Development for Poisoning – Comparative Analysis, H1 2012
Number of Products under Development by Companies, H1 2012
Number of Products under Investigation by Universities/Institutes, H1 2012
Comparative Analysis by Late Stage Development, H1 2012
Comparative Analysis by Mid Clinical Stage Development, H1 2012
Comparative Analysis by Early Clinical Stage Development, H1 2012
Comparative Analysis by Pre-Clinical Stage Development, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Cangene Corporation, H1 2012
Protalix BioTherapeutics, Inc., H1 2012
Aton Pharma, Inc., H1 2012
MicroDose Therapeutx, Inc., H1 2012
Instituto Bioclon S.A. de C.V., H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Poisoning Therapeutics – Drug Profile Updates
Poisoning Therapeutics – Dormant Products

List of Figures
Number of Products under Development for Poisoning, H1 2012
Products under Development for Poisoning – Comparative Analysis, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Late Stage Products, H1 2012
Mid Clinical Stage Products, H1 2012
Early Clinical Stage Products, H1 2012
Pre-Clinical Stage Products, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Route of Administration, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Assessment by Stage and Molecule Type, H1 2012

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos